ENDRA Life Sciences NDRA
NASDAQ NDRA
$4.80 +0.02 (+0.42%)
As of: Oct 23, 2026 · 3:57 PM EDT

ENDRA Life Sciences (NDRA) Non Operating Investment Income (2026)

Updated

ENDRA Life Sciences' Non Operating Investment Income was $1.29 million in Q2 2026, up 74.9% from the prior quarter.

Analysis

ENDRA Life Sciences (NDRA) Non Operating Investment Income (2026) Analysis & Trends

For FY2025, Non Operating Investment Income at ENDRA Life Sciences came in at -$995,161.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Thermo Fisher Scientific 250.13 Bn 229.16 Bn 4.88 Bn -
2 Abbott Laboratories 180.31 Bn 150.74 Bn 7.27 Bn -
3 Danaher 162.34 Bn 146.15 Bn 3.61 Bn -
4 Intuitive Surgical 158.13 Bn 138.42 Bn 2.08 Bn -
5 Medtronic 122.37 Bn 87.63 Bn 6.34 Bn -
6 Stryker 117.89 Bn 104.00 Bn 4.50 Bn -
7 Boston Scientific 67.15 Bn 61.92 Bn 3.85 Bn -
8 Becton Dickinson 54.68 Bn 51.83 Bn 2.32 Bn -
9 Edwards Lifesciences 51.43 Bn 35.44 Bn 1.35 Bn -
10 ENDRA Life Sciences 6.36 Mn 2.70 Mn - 1.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.29 Mn
Mar 31, 2026 738,177.00
API Access

ENDRA Life Sciences Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=NDRA&period=max&api_key=YOUR_API_KEY